Clinical Trial Update: A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of single and repeated doses of glucagon in participants with diabetes was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED | Results posted: 2019-12-13